Articles liés à The WTO Medicines Decision in light of its Utilization:...

The WTO Medicines Decision in light of its Utilization: Resolution or Resignation? - Couverture souple

Nkomo, Marumo

 
9783838373607: The WTO Medicines Decision in light of its Utilization: Resolution or Resignation?
Couverture souple
ISBN 10 : 383837360X ISBN 13 : 9783838373607
Editeur : LAP LAMBERT Academic Publishing, 2010

Synopsis

Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organization (WTO) Members to devise a solution for countries whose dearth in pharmaceutical manufacturing capacity rendered them unable to effectively use compulsory licensing as a public interest tool. Two years later, WTO Members followed on from Doha by creating a special mechanism to allow Members with sufficiently strong pharmaceutical sectors to issue compulsory licenses for the sole purpose of export to paragraph 6 countries. The formal name for this Mechanism is the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health; however it is colloquially known inter alia as the 30 August decision. Five years on from the adoption of the 30 August decision, only one example of its utilization exists, that of Canada (as exporter) and Rwanda (as importer). This book restates the background to the 30 August decision and adds to the existing literature analysing it in order to assess how effective it is likely to prove in addressing the paragraph 6 mandate...

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Présentation de l'éditeur

Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) mandated World Trade Organization (WTO) Members to devise a solution for countries whose dearth in pharmaceutical manufacturing capacity rendered them unable to effectively use compulsory licensing as a public interest tool. Two years later, WTO Members followed on from Doha by creating a special mechanism to allow Members with sufficiently strong pharmaceutical sectors to issue compulsory licenses for the sole purpose of export to paragraph 6 countries. The formal name for this Mechanism is the Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health; however it is colloquially known inter alia as the 30 August decision. Five years on from the adoption of the 30 August decision, only one example of its utilization exists, that of Canada (as exporter) and Rwanda (as importer). This book restates the background to the 30 August decision and adds to the existing literature analysing it in order to assess how effective it is likely to prove in addressing the paragraph 6 mandate...

Biographie de l'auteur

is a South African national and currently works with a leading Intellectual Property law firm. He holds two Master's degrees; these include an LLM in International Trade and Investment Law from the University of Pretoria?s Centre for Human Rights and a Master of International Law and Economics from the World Trade Institute in Bern, Switzerland.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Éditeur
LAP LAMBERT Academic Publishing
Date d'édition
2010
Langue
anglais
ISBN 10 
383837360X
ISBN 13 
9783838373607
Reliure
Broché
Nombre de pages
80
Coordonnées du fabricant
non disponible
Personne responsable
KreGa Onlinehandel GmbH
4950000000000
info@krega-onlinehandel.de

Birkenweg 31
Brakel
33034
Allemagne